Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
VentolinSalbutamol100 DosesCFC Free InhalerThe Accuhaler is a combination of a mouthpiece and an Accuhaler mouthpiece, which is used to ensure that the medication is not mistakenly swallowed. This information is for the advice of a doctor and does not take the place of your individual health needs. If you are to use the Accuhaler with a prescription, it is important to follow the instructions on the Accuhaler mouthpiece and Accuhaler mouthpiece. If you are using the Accuhaler with a mask or an accuhaler, it is also important to note that the Accuhaler is not for mask- situ detection. In the case of Accuhaler Accuhaler 1, the Accuhaler Accuhaler 1 Accuhaler Accuhaler Accuhaler is a mask- situ detection. In the case of Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1, the Accuhaler Accuhaler 1 Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler 1 is a mask- situ detection. In the case of Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1, it is important to note that Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 Accuhaler 1 is a Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler 1 Accuhaler Accuhaler Accuhaler 1 Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler 1, and Accuhaler 1 Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler 1 is a mask- situ detection.
Please note that you should not use the Accuhaler Accuhaler Accuhaler Accuhaler 1 Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler Accuhaler when you are taking a medication for asthma, chronic obstructive pulmonary disease or other breathing conditions.
ventolin inhaler (also known by its generic name salbutamol) is a small, high-polarity inhalation aerosol produced by the company Advair Pharmaceuticals that is used for the treatment of bronchospasm in patients with asthma. It is used in the treatment of mild to moderate asthma that affects the airways of the lungs and the bronchi. It can also be used to treat severe asthma that affects the lungs. Ventolin is a selective beta2-adrenergic agonist and is thought to cause more bronchodilation than other bronchodilators. It is thought to cause more bronchospasm than other bronchodilators. It is thought to cause less mucus secretion and less mucous secretion, which can also be an indication of bronchospasm. Ventolin inhalers are used as rescue inhalers or maintenance therapy when a patient is unable to breathe through an inhaler. It is also used in the treatment of severe bronchospasm to prevent further bronchospasm. It can be used in combination with other bronchodilators as needed to treat bronchospasm in patients with severe bronchospasm.
Salbutamol is used to treat moderate to severe bronchospasm in patients with asthma as part of a combination therapy with other bronchodilators. This therapy is not indicated in patients without asthma and should only be used to relieve mild symptoms. The use of this inhaler is restricted to patients aged 50 years and older. It should not be used by children as it can cause permanent bronchospasm.
Salbutamol is also used to prevent further bronchospasm in patients with severe COPD. It is not approved for use by the paediatric population in clinical trials, nor for use by children.
Patients with a history of asthma should not use salbutamol. Patients with a history of COPD should not use salbutamol. Patients with a history of bronchospasm and patients with a history of asthma should use salbutamol as needed to prevent further bronchospasm.
Salbutamol should not be used to treat moderate to severe bronchospasm in patients with asthma as it is not approved for use by the paediatric population. It should not be used by children.
Patients with a history of COPD should use salbutamol as needed to prevent further bronchospasm.
Patients using salbutamol should use a small, high-polarity, pressurized, inhalation aerosol inhaler with the mouthpiece in the appropriate dose. Patients should inhale the aerosol to the lowest dose possible while they are taking salbutamol. Patients should take the inhaler with them at least 30 minutes before using the inhaler. The device should be cleaned and dry with an equal amount of water before use. Patients should not open the mouthpiece until the inhaler is finished. The device should not be used more than once in 24 hours. Patients should not open the mouthpiece longer than 10 inches before using the device. Patients should not inhale the inhaler while they are using the device.
Patients with a history of asthma should use a bronchodilator. The medication should not be used for more than 10 days before or after a dose of salbutamol. Patients should not use salbutamol for more than 10 days before or after a dose of salbutamol.
Ventolin is a prescription medicine used to treat bronchospasm in people with asthma. It belongs to a class of drugs known as short-acting reversible beta-agonists (sAPBAs). It works by relaxing muscles in the airway passages and widening the airways.
Ventolin is also used to relieve cough and cold symptoms in people with bronchospasm. Ventolin is also prescribed to treat symptoms of wheezing, shortness of breath, and shortness of breath caused by asthma.
Ventolin is available as a generic inhaler. It contains the active ingredient salbutamol. This inhaler works by stopping the body from releasing more salbutamol. Ventolin inhalers are available in different strengths and are available in the following strengths: 1.5mg, 2.5mg, 5mg, 7.5mg, 10mg and 15mg inhalers.
Ventolin is a prescription medicine. However, this is not a complete list of inhalers available to treat bronchospasm.
Ventolin is used to treat the symptoms of bronchospasm in people with asthma. Ventolin is also used to treat the symptoms of wheezing, shortness of breath, and shortness of breath caused by asthma. Ventolin is also used to treat shortness of breath and cough.
Ventolin inhalers should be used only when prescribed by a doctor. The recommended dose of Ventolin inhalers is inhalation. To use this medicine, follow these steps:
Before using Ventolin,
Ventolin can cause side effects, including:
If any of these side effects persist or worsen, tell your doctor or pharmacist promptly.
To avoid side effects, use this medication only as directed by a doctor or as prescribed by your doctor.
Before using this medication, tell your doctor or pharmacist your medical history, especially of:
This is not a complete list of Ventolin side effects, which can occur with use of this medication.
Ventolin HFA, also known as Ventolin HFA, is an inhaler used to treat high-dose bronchospasm in patients with asthma. The drug contains the same active ingredient, albuterol, as Salbutamol (salbutamol). VENTOLIN HFA is a fast-acting bronchodilator that allows for quick relief from bronchospasm and is particularly beneficial for patients with asthma. VENTOLIN HFA is available in both an inhaler and an inhaler-like device that contains a propellant that can deliver an aerosolizer, or spray, to the airways, in the form of a puff. It is important to note that VENTOLIN HFA may not be suitable for all patients.
Ventolin HFA is a quick-relief inhaler that is designed to be used as a first aid and to prevent the inhaler from opening. It works by relaxing the muscles around the airways, allowing for better airflow to the lungs. VENTOLIN HFA inhaler is a fast-acting, non-invasive treatment that can be used to treat asthma and other respiratory conditions. This fast-acting formulation of VENTOLIN HFA provides rapid relief of bronchospasm in patients with asthma and is used as part of a comprehensive treatment plan to prevent asthma exacerbations. Ventolin HFA is an alternative to other inhaled medications such as albuterol, and provides the same effects as VENTOLIN HFA and Salbutamol.
VENTOLIN HFA is a bronchodilator that is used to treat bronchospasm in patients with asthma. It is a short-acting beta2-agonist (SABA) that is part of a combination therapy plan that combines two inhaled medications, Ventolin HFA and Salbutamol. These two medications work together to reduce the production of a chemical called bronchospasm in patients with asthma. The Ventolin HFA inhaler is an advanced, fast-acting bronchodilator that has been shown to provide relief of asthma symptoms and prevent bronchospasm.
VENTOLIN HFA inhaler provides a fast-acting, fast-relief treatment option for patients with asthma. The Ventolin HFA inhaler is a fast-acting, fast-relief inhaler that is used as part of a comprehensive treatment plan to prevent bronchospasm and prevent asthma symptoms. Ventolin HFA inhaler provides a fast-acting, fast-relief treatment option for patients with asthma.
Product name:VENTOLIN INHALER
Company name:
DIN:0212514
Status:Marketed
Status date:2001-12-15
Active ingredient(s) | Strength |
---|---|
VENTOLIN (ALFENOSE) | 25 MG |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumersResource | Description |
---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |